Latest news
NeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:48:44 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTYale Study Finds Face-Related Brain Signals Sharpen with Age in Neurotypical Children but Not in Autistic Children - Medical DailyMedical Daily · Wed, 05 Aug 2026 01:30:40 GMTCT hospitals seeing 50% more psychiatric crises since 2019. How they’re adapting - Hartford CourantHartford Courant · Wed, 29 Jul 2026 09:39:57 GMT